Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: Multicenter survey in Korea

Clinical Cardiology

Volumn 35, Issue 11, 2012, Pages 700-706

  Kim, Mi Jeong ^a   Jeon, Doo Soo ^a   Gwon, Hyeon Cheol ^b   Kim, Soo Joong ^c   Chang, Kiyuk ^d   Kim, Hyo Soo ^e   Tahk, Seung Jea ^f  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Seoul National University Hospital   (South Korea)

^f Ajou University Medical CentSuwon   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ROSUVASTATIN; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE REGISTRY; DRUG MEGADOSE; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INDEPENDENT VARIABLE; KOREA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; CHI-SQUARE DISTRIBUTION; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FEMALE; FLUOROBENZENES; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PYRIMIDINES; PYRROLES; REGISTRIES; REPUBLIC OF KOREA; RISK FACTORS; SULFONAMIDES; TIME FACTORS;

EID: 84869446093     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22038     Document Type: Article

References (19)

1. Ray KK, Cannon CP, McCabe CH, et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005; 46: 1405-1410. (Pubitemid 41446173)
2. Kim JS, Kim J, Choi D, et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI Trial. JACC Cardiovasc Interv. 2010; 3: 332-339.
3. Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007; 49: 1272-1278. (Pubitemid 46467240)
4. Patti G, Cannon CP, Murphy SA, et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation. 2011; 123: 1622-1632.
5. Members WC, Levine GN, Bates ER, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary. Circulation. 2011; 124: 2574-2609.
6. Thygesen K, Alpert JS, White HD., Universal definition of myocardial infarction. Eur Heart J. 2007; 28: 2525-2538. (Pubitemid 47616190)
7. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007; 116: e148-e304.
8. King SB, Smith SC, Hirshfeld JW, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008; 117: 261-295.
9. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995; 25: 333-341.
10. The EuroQol Group. EuroQolâ€"a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16: 199-208.
11. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA. 2001; 285: 1711-1718.
12. Yun KH, Shin IS, Shin SN, et al. Effect of previous statin therapy in patients with acute coronary syndrome and percutaneous coronary intervention. Korean Circ J. 2011; 41: 458-463.
13. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011; 57: e215-e367.
14. Sposito AC, Santos SN, de Faria EC, et al. Timing and dose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction. Arterioscler Thromb Vasc Biol. 2011; 31: 1240-1246.
15. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349: 2117-2127. (Pubitemid 37464537)
16. Ross JS, Normand SL, Wang Y, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010; 362: 1110-1118.
17. Kanhere M, Kanhere H, Cameron A, et al. Does patient volume affect clinical outcomes in adult intensive care units? Intensive Care Med. 2012; 38: 741-751.
18. Lee JH, Yang DH, Park HS, et al. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J. 2010; 159: 1012-1019.
19. Elbarouni B, Banihashemi SB, Yan RT, et al. Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE experience). Am J Cardiol. 2012; 109: 1418-1424.